GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » Interest Paid

Oxurion NV (FRA:TG40) Interest Paid


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV Interest Paid?

Interest Paid only applicable to companies reporting Cash Flow from Operations in direct method.


Oxurion NV Business Description

Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.